•
Jun 30, 2020

AMN Healthcare Q2 2020 Earnings Report

AMN Healthcare's Q2 2020 financial results were announced, showing revenue growth and adaptability amidst the COVID-19 pandemic.

Key Takeaways

AMN Healthcare reported a 14% increase in revenue to $608 million for Q2 2020. The company's adjusted EPS was $0.83, and they reduced debt by $127 million, achieving a leverage ratio of 2.7 to 1.

AMN team members and healthcare professionals played a crucial role in caring for COVID-19 patients.

The company increased diversity, inclusion, equity, and equality actions.

Q2 financial results exceeded expectations, driven by travel nurse staffing and the recovery of Stratus Video.

Operating cash flow was $77 million, enabling debt reduction.

Total Revenue
$608M
Previous year: $535M
+13.7%
EPS
$0.83
Previous year: $0.77
+7.8%
Gross Profit
$198M
Previous year: $180M
+10.0%
Cash and Equivalents
$43.1M
Previous year: $20.9M
+105.7%
Free Cash Flow
$70.8M
Previous year: $20.9M
+238.0%
Total Assets
$2.36B
Previous year: $1.86B
+27.4%

AMN Healthcare

AMN Healthcare

AMN Healthcare Revenue by Segment

Forward Guidance

The company projects consolidated third quarter revenue to be in a range of $510 million to $525 million. Third quarter gross margin is expected to be 33.0-33.5%, operating margin is expected to be above 7%, and adjusted EBITDA margin is expected to be greater than 13%.

Positive Outlook

  • Travel nurse staffing revenue is expected to be up 3-5% to prior year.
  • Language interpretation business has experienced steady growth in billable minutes since May, which we expect will continue through the third quarter
  • Third quarter gross margin is expected to be 33.0-33.5%.
  • Operating margin is expected to be above 7%.
  • Adjusted EBITDA margin is expected to be greater than 13%.

Challenges Ahead

  • COVID-19 pandemic has been highly disruptive to economic activity and to healthcare infrastructure
  • Healthcare labor demand is volatile.
  • Elective procedures and routine care are still below pre-crisis levels.
  • Allied revenue is expected to be lower than prior year by 27-29%
  • Physician and Leadership Solutions segment revenue estimated at nearly 30% below prior year.